Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken ...
Even one fall by an older adult is just as accurate in predicting cognitive decline as individuals with elevated amyloid, the ...
For over thirty years, researchers have primarily studied the accumulation of amyloid beta proteins in the brains of Alzheimer’s patients. They also focus on how that component negatively impacts ...
New paper from UC Santa Cruz chemistry lab argues that efforts to develop treatments for Alzheimer's should stop ignoring a ...
Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the ...
Evgeny Raskatov, a biochemist at the University of California, Santa Cruz, found out that in addition to beta-amyloid, which ...
These new drugs have transformed research into new therapies. There are more clinical trials in Alzheimer’s than ever before. Studies indicate other pathways besides the amyloid protein that ...
Amyloid beta is a peptide that plays a central role in the neurodegenerative pathology of Alzheimer’s disease by aggregating into plaques in the brain. U.S. Food and Drug Administration (FDA) approved ...
The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy transthyretin moves hormones through blood and spinal fluid, misfolded ...
Researchers have identified a natural compound from pomegranate leaves and branches that can directly dismantle the protein aggregates responsible for transthyretin amyloidosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results